Free Trial
NASDAQ:IMMP

Prima BioMed (IMMP) Stock Price, News & Analysis

Prima BioMed logo
$1.68 -0.04 (-2.33%)
As of 04:00 PM Eastern

About Prima BioMed Stock (NASDAQ:IMMP)

Key Stats

Today's Range
$1.66
$1.74
50-Day Range
$1.52
$2.49
52-Week Range
$1.32
$2.72
Volume
112,586 shs
Average Volume
191,835 shs
Market Capitalization
$245.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Buy

Company Overview

Prima BioMed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
19th Percentile Overall Score

IMMP MarketRank™: 

Prima BioMed scored higher than 19% of companies evaluated by MarketBeat, and ranked 839th out of 913 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Prima BioMed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Prima BioMed has received no research coverage in the past 90 days.

  • Read more about Prima BioMed's stock forecast and price target.
  • Earnings Growth

    Earnings for Prima BioMed are expected to decrease in the coming year, from ($0.40) to ($0.50) per share.

  • Price to Book Value per Share Ratio

    Prima BioMed has a P/B Ratio of 1.60. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Prima BioMed's valuation and earnings.
  • Percentage of Shares Shorted

    2.96% of the float of Prima BioMed has been sold short.
  • Short Interest Ratio / Days to Cover

    Prima BioMed has a short interest ratio ("days to cover") of 14.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Prima BioMed has recently increased by 1.21%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Prima BioMed does not currently pay a dividend.

  • Dividend Growth

    Prima BioMed does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.96% of the float of Prima BioMed has been sold short.
  • Short Interest Ratio / Days to Cover

    Prima BioMed has a short interest ratio ("days to cover") of 14.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Prima BioMed has recently increased by 1.21%, indicating that investor sentiment is decreasing.
  • Search Interest

    3 people have searched for IMMP on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 1 people have added Prima BioMed to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Prima BioMed insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.07% of the stock of Prima BioMed is held by insiders.

  • Percentage Held by Institutions

    Only 2.32% of the stock of Prima BioMed is held by institutions.

  • Read more about Prima BioMed's insider trading history.
Receive IMMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prima BioMed and its competitors with MarketBeat's FREE daily newsletter.

IMMP Stock News Headlines

$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
See More Headlines

IMMP Stock Analysis - Frequently Asked Questions

Prima BioMed's stock was trading at $2.17 at the start of the year. Since then, IMMP shares have decreased by 22.6% and is now trading at $1.68.

Shares of IMMP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Prima BioMed investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), Pfizer (PFE), Broadcom (AVGO) and GE Aerospace (GE).

Company Calendar

Today
7/07/2025
Next Earnings (Estimated)
7/29/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IMMP
Employees
2,021
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.00
High Stock Price Target
$7.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+309.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.14 million
Price / Cash Flow
N/A
Book Value
$1.05 per share
Price / Book
1.63

Miscellaneous

Free Float
141,556,000
Market Cap
$249.73 million
Optionable
Optionable
Beta
1.71

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:IMMP) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners